Terminal
Stocks
Spotlight
News

Stocks
Basic Materials
OTC
PURE

Market Cap: $11.7M

PI

PURE Bioscience, Inc.

PURE

OTC (Other OTC)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin538.04%

EBITDA Margin7.64%

EBIT Margin-74.90%

Pre-tax Margin-91.04%

Net Profit Margin-91.04%

Earnings Yield-33.16%

Valuation Multiples

Price / Book-1.14

Price / Sales3.22

Price / Earnings-3.05

PEG-0.13

Forward PEG-0.13

EV / Sales5.50

EV / EBITDA71.97

EV / Operating Cash Flow-7.48

EV / Free Cash Flow-7.48

Price / Free Cash Flow-4.38

Price / Operating Cash Flow-3.74

Cash Flow & Capital

Free Cash Flow / Share-$0.02

Operating Cash Flow / Share-$0.02

Free Cash Flow Yield-22.82%

Capex / Revenue0.00%

Capex / Operating Cash Flow0.00%

Capex / Depreciation0.00

Stock Compensation / Revenue60.71%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio0.42

Quick Ratio0.36

Cash Ratio0.27

Debt / Assets4.17

Debt / Capital9.87

Debt / Equity-1.11

Long-Term Debt / Capital-1.79

Debt / Market Cap83.28%

Net Debt / EBITDA29.81

Solvency Ratio-0.03

Financial Leverage-0.27

Efficiency & Working Capital

Asset Turnover1.55

Fixed Asset Turnover269.11

Inventory Turnover3875.42

Receivables Turnover10.01

Payables Turnover1250.48

Days Sales Outstanding36.47

Days Inventory Outstanding0.09

Days Payables Outstanding0.29

Operating Cycle36.56

Cash Conversion Cycle36.27

Working Capital Turnover-1.11

Returns & Quality

Return on Equity38.73%

Return on Assets-1.42%

Return on Invested Capital-2.91%

ROCE91.41%

Return on Tangible Assets-1.42%

Operating Return on Assets-1.63%

Income Quality0.00

Tax Burden1.00

Interest Burden1.22

Balance Sheet & Intrinsic Metrics

Enterprise Value$13.32M

Invested Capital$-2.1M

Working Capital$-2.11M

Tangible Asset Value$-5.84M

Net Current Asset Value$-5.85M

Graham Net-Net-$0.06

Book Value / Share-$0.05

Tangible Book Value / Share-$0.05

Cash / Share$0.01

Financial Health Scores

Piotroski Score3

Altman Z-Score-129.86

Revenue$2.42M

EBIT$-1.82M

Market Cap$7.8M

Working Capital$-2.11M

Retained Earnings$-140.87M

Total Assets$1.56M

Total Liabilities$7.4M